Rapid T Cell Engineering to Counter Emerging Threats

Executive Summary

We will revolutionize countermeasure development for emerging threats by developing a rapid, facile method to engineer epitope responsive T cells, and provide a pipeline to rapidly screen and select candidates for therapeutic use against any pathogen. If successful, this work will establish an entirely new class of therapeutics for emerging biological threats and demonstrate the pipeline to rapidly screen and select candidates for therapeutic use.